"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
Descriptor ID |
D015996
|
MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 31 | 31 |
1995 | 0 | 34 | 34 |
1996 | 0 | 22 | 22 |
1997 | 0 | 33 | 33 |
1998 | 0 | 43 | 43 |
1999 | 0 | 28 | 28 |
2000 | 0 | 36 | 36 |
2001 | 0 | 30 | 30 |
2002 | 0 | 30 | 30 |
2003 | 1 | 32 | 33 |
2004 | 0 | 32 | 32 |
2005 | 0 | 32 | 32 |
2006 | 0 | 34 | 34 |
2007 | 0 | 24 | 24 |
2008 | 0 | 55 | 55 |
2009 | 0 | 40 | 40 |
2010 | 0 | 70 | 70 |
2011 | 0 | 77 | 77 |
2012 | 0 | 57 | 57 |
2013 | 1 | 58 | 59 |
2014 | 0 | 58 | 58 |
2015 | 0 | 53 | 53 |
2016 | 0 | 56 | 56 |
2017 | 0 | 56 | 56 |
2018 | 0 | 42 | 42 |
2019 | 0 | 83 | 83 |
2020 | 0 | 57 | 57 |
2021 | 0 | 34 | 34 |
2022 | 0 | 10 | 10 |
2023 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2024 Jan; 31(1):645-654.
-
Doublet vs. Triplet Systemic Chemotherapy for High Grade Appendiceal Adenocarcinoma with Peritoneal Metastases. J Gastrointest Surg. 2023 Nov; 27(11):2560-2562.
-
Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery. Ann Surg. 2023 12 01; 278(6):925-931.
-
Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US. JAMA Netw Open. 2023 03 01; 6(3):e235834.
-
PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 May; 30(5):3114-3122.
-
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5):831-840.
-
Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2023 03; 283:1154-1160.
-
Evaluation of National Institutes of Health cardiac arrest research based on "chain of survival" links. Acad Emerg Med. 2022 Nov; 29(11):1381-1382.
-
Survival in Total Preoperative vs. Perioperative Chemotherapy for Patients with Metastatic High-Grade Appendiceal Adenocarcinoma Undergoing CRS/HIPEC. J Gastrointest Surg. 2022 12; 26(12):2591-2594.
-
Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. J Card Fail. 2022 07; 28(7):1158-1168.